Passengers, drivers, and "goners".
作者信息
Bunz Fred
机构信息
The Department of Radiation Oncology and Molecular Radiation Sciences and the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
出版信息
Int J Cancer. 2024 Nov 1;155(9):1696-1698. doi: 10.1002/ijc.35112. Epub 2024 Jul 26.
Abstract
摘要
相似文献
1
Passengers, drivers, and "goners".乘客、司机和“将死者”。
Int J Cancer. 2024 Nov 1;155(9):1696-1698. doi: 10.1002/ijc.35112. Epub 2024 Jul 26.
2
Teen Drivers' Perceptions of Their Peer Passengers: Qualitative Study.青少年驾驶员对同乘乘客的认知：定性研究
Transp Res Rec. 2015;2516:22-26. doi: 10.3141/2516-04.
3
The prevalence of seat belt use among drivers and passengers: a systematic review and meta-analysis.驾驶员和乘客使用安全带的患病率：一项系统评价和荟萃分析。
J Egypt Public Health Assoc. 2023 Aug 2;98(1):14. doi: 10.1186/s42506-023-00139-3.
4
Conflicts between bus drivers and passengers in Changsha, China.中国长沙的公交车司机与乘客之间的冲突。
Accid Anal Prev. 2022 May;169:106623. doi: 10.1016/j.aap.2022.106623. Epub 2022 Mar 8.
5
Drivers with child passengers: distracted but cautious?有儿童乘客的驾驶员：注意力分散但谨慎？
Accid Anal Prev. 2019 Oct;131:25-32. doi: 10.1016/j.aap.2019.06.004. Epub 2019 Jun 21.
6
Severity and injury characteristics among matched hospitalized motorcycle drivers and their passengers.匹配的住院摩托车驾驶员及其乘客的严重程度和损伤特征。
Chin J Traumatol. 2019 Aug;22(4):223-227. doi: 10.1016/j.cjtee.2018.08.007. Epub 2019 May 2.
7
Drivers' attitudes toward front or rear child passenger belt use and seat belt reminders at these seating positions.驾驶员对前向或后向儿童乘客安全带使用以及这些座位位置上的安全带提醒的态度。
Traffic Inj Prev. 2014;15(3):278-86. doi: 10.1080/15389588.2013.810333.
8
Is seat belt usage by front seat passengers related to seat belt usage by their drivers?前排乘客使用安全带的情况与他们的司机使用安全带的情况有关吗？
J Safety Res. 2007;38(5):545-55. doi: 10.1016/j.jsr.2007.06.002. Epub 2007 Oct 3.
9
Nothing good ever happens after midnight: observed exposure and alcohol use during weekend nights among young male drivers carrying passengers in a late licensing country.午夜之后不会有好事发生：在一个驾照发放较晚的国家，年轻男性司机搭载乘客时在周末夜间的观察到的暴露情况和酒精使用情况。
Accid Anal Prev. 2015 Feb;75:61-8. doi: 10.1016/j.aap.2014.11.014. Epub 2014 Nov 22.
10
Comparison of injuries sustained by drivers and pillion passengers in fatal head-on motorcycle collision accidents.正面碰撞摩托车事故中司机和后座乘客受伤情况的比较。
Forensic Sci Int. 2011 Apr 15;207(1-3):188-92. doi: 10.1016/j.forsciint.2010.10.003. Epub 2010 Oct 28.
引用本文的文献
1
Estimating the Number of Polygenic Diseases Among Six Mutually Exclusive Entities of Non-Tumors and Cancer.估计六种非肿瘤和癌症相互排斥实体中的多基因疾病数量。
Int J Mol Sci. 2024 Nov 7;25(22):11968. doi: 10.3390/ijms252211968.
本文引用的文献
1
New Means and Challenges in the Targeting of BTK.BTK 靶向的新方法和新挑战
Clin Cancer Res. 2024 Jun 3;30(11):2333-2341. doi: 10.1158/1078-0432.CCR-23-0409.
2
Reduced clone size upon BTK inhibitor resistance mutations relates to toxicity caused by inherited PLCG2 gain-of-function variations.布鲁顿酪氨酸激酶（BTK）抑制剂耐药性突变后克隆大小减小与遗传性磷脂酶Cγ2（PLCG2）功能获得性变异所导致的毒性相关。
Eur J Haematol. 2024 Jul;113(1):130-131. doi: 10.1111/ejh.14204. Epub 2024 Mar 26.
3
PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variants.PLCG2 相关免疫失调 (PLAID) 包括与遗传变异功能类别相关的广泛而不同的临床表现。
J Allergy Clin Immunol. 2024 Jan;153(1):230-242. doi: 10.1016/j.jaci.2023.08.036. Epub 2023 Sep 26.
4
BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib.在伊布替尼治疗后复发的 CLL 患者中，有三分之一的患者 BTK 和 PLCG2 未发生突变。
Blood Adv. 2023 Jun 27;7(12):2794-2806. doi: 10.1182/bloodadvances.2022008821.
5
Single-cell sequencing demonstrates complex resistance landscape in CLL and MCL treated with BTK and BCL2 inhibitors.单细胞测序技术揭示了 BTK 和 BCL2 抑制剂治疗 CLL 和 MCL 中的复杂耐药机制。
Blood Adv. 2022 Jan 25;6(2):503-508. doi: 10.1182/bloodadvances.2021006211.
6
Prevalence of and mutations in a real-life CLL cohort still on ibrutinib after 3 years: a FILO group study.真实世界 CLL 队列中伊布替尼治疗 3 年后仍存在 和 突变的流行率：一项 FILO 研究。
Blood. 2019 Aug 15;134(7):641-644. doi: 10.1182/blood.2019000854. Epub 2019 Jun 26.
7
BTK-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia.布鲁顿酪氨酸激酶介导的慢性淋巴细胞白血病对依鲁替尼的耐药性
J Clin Oncol. 2017 May 1;35(13):1437-1443. doi: 10.1200/JCO.2016.70.2282. Epub 2017 Feb 13.
8
Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia.伊布替尼治疗中断的病因及慢性淋巴细胞白血病患者的结局。
JAMA Oncol. 2015 Apr;1(1):80-7. doi: 10.1001/jamaoncol.2014.218.
9
Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib.伊布替尼的布鲁顿酪氨酸激酶抑制剂耐药机制。
N Engl J Med. 2014 Jun 12;370(24):2286-94. doi: 10.1056/NEJMoa1400029. Epub 2014 May 28.
10
Cancer genome landscapes.肿瘤基因组图谱。
Science. 2013 Mar 29;339(6127):1546-58. doi: 10.1126/science.1235122.
Zotero 插件